SCHEMBL2235488

SCHEMBL2235488

CN(C)Cc1cccc(NS(=O)(=O)c2ccc(-c3ncccn3)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.53
MAPT P10636 2/20 0.49
CYP3A4 P08684 1/20 0.49
NMT1 P30419 6/20 0.48
LIMK2 P53671 5/20 0.47
LIMK1 P53667 2/20 0.47
MEN1 O00255 1/20 0.47
PKM P14618 1/20 0.47
KMT2A Q03164 1/20 0.47
IKBKB O14920 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PTGES O14684 1/20 0.46
ALDH1A1 P00352 1/20 0.46
ABL1 P00519 1/20 0.46
LCK P06239 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2237620 0.89 LIMK2 (0.51) HTR6MAPTCYP3A4NMT1LIMK2
SCHEMBL10093361 0.83 HTR6 (0.50) HTR6MAPTNMT1LIMK2LIMK1
SCHEMBL2305394 0.82 HTR6 (0.75) HTR6LIMK2LIMK1MEN1PKM
SCHEMBL2236047 0.81 HTR6 (0.59) HTR6MAPTNMT1LIMK2LIMK1
SCHEMBL2238500 0.79 HTR6 (0.47) HTR6MAPTNMT1LIMK2LIMK1
SCHEMBL2235116 0.78 HTR6 (0.58) HTR6LIMK2LIMK1IKBKBPTGES
SCHEMBL2237501 0.77 CYP19A1 (0.53) HTR6MAPTNMT1LIMK2LIMK1
SCHEMBL28470500 0.72 ALDH1A1 (0.59) HTR6MAPTCYP3A4MEN1PKM
SCHEMBL2888719 0.71 IKBKB (0.64) HTR6MAPTLIMK2LIMK1IKBKB
SCHEMBL15232980 0.69 CYP19A1 (0.66) HTR6MAPTCYP3A4MEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA HTR6 4577/4885MAPT 633/4885CYP3A4 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.